Format

Send to

Choose Destination
Mol Endocrinol. 2009 Oct;23(10):1525-31. doi: 10.1210/me.2009-0069. Epub 2009 May 28.

Minireview: live and let die: molecular effects of glucocorticoids on bone cells.

Author information

1
Division of Endocrinology, Diabetes, and Bone Diseases, Department of Medicine III, Technical University of Dresden, Fetscherstrasse 74, D-01307 Dresden, Germany. lorenz.hofbauer@uniklinikum-dresden.de

Abstract

Glucocorticoids (GCs) are efficient drugs that are used to treat various immune-mediated diseases, but their long-term administration is associated with multiple metabolic side effects, including osteoporosis. Molecular analyses of the mechanisms exerted by the GC receptor have resulted in the development of GC receptor agonists that selectively repress or activate GC target genes. This review summarizes the cellular and molecular effects of GCs on bone cells and highlights the critical signaling pathways that may evolve into future therapeutic strategies.

PMID:
19477950
PMCID:
PMC5419139
DOI:
10.1210/me.2009-0069
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center